Emergency gastrointestinal surgery in patients undergoing antithrombotic therapy in a single general hospital: a propensity score-matched analysis.


Journal

BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547

Informations de publication

Date de publication:
21 Aug 2021
Historique:
received: 23 04 2021
accepted: 11 08 2021
entrez: 22 8 2021
pubmed: 23 8 2021
medline: 25 8 2021
Statut: epublish

Résumé

This study aimed to review and evaluate the surgical outcomes, particularly intraoperative severe blood loss and postoperative blood complications, of emergency gastrointestinal surgery in patients undergoing antithrombotic therapy (AT). Emergency surgeries for patients with antithrombotic medication have been increasing in the aging population. However, the effect of AT on intraoperative blood loss and perioperative complications remains unclear. We retrospectively reviewed 732 patients who underwent emergency gastrointestinal surgery between April 2014 and March 2019. Patients were classified into AT group and Non-AT group, and propensity score-matched analysis was performed to compare the short surgical outcomes between the groups. Additionally, risk factors in severe estimated blood loss (EBL) and postoperative bleeding complications were assessed. Altogether, 64 patients received AT; 50 patients and 12, and 2 were given antiplatelet and anticoagulant, and both drugs, respectively. After propensity score matching, EBL (101 vs. 99 mL; p = 0.466) and postoperative complications (14 vs. 16 patients; p = 0.676) were similar between the groups (63 patients matched paired). Intraoperative severe bleeding (EBL ≥ 492 mL) occurred in 44 patients. Multivariate analysis using the full cohort revealed that antithrombotic drug use was not an independent risk factor for severe bleeding and postoperative bleeding complications. This study demonstrated antithrombotic drugs do not adversely affect the perioperative outcomes of emergency gastrointestinal surgery.

Sections du résumé

BACKGROUND BACKGROUND
This study aimed to review and evaluate the surgical outcomes, particularly intraoperative severe blood loss and postoperative blood complications, of emergency gastrointestinal surgery in patients undergoing antithrombotic therapy (AT). Emergency surgeries for patients with antithrombotic medication have been increasing in the aging population. However, the effect of AT on intraoperative blood loss and perioperative complications remains unclear.
METHODS METHODS
We retrospectively reviewed 732 patients who underwent emergency gastrointestinal surgery between April 2014 and March 2019. Patients were classified into AT group and Non-AT group, and propensity score-matched analysis was performed to compare the short surgical outcomes between the groups. Additionally, risk factors in severe estimated blood loss (EBL) and postoperative bleeding complications were assessed.
RESULTS RESULTS
Altogether, 64 patients received AT; 50 patients and 12, and 2 were given antiplatelet and anticoagulant, and both drugs, respectively. After propensity score matching, EBL (101 vs. 99 mL; p = 0.466) and postoperative complications (14 vs. 16 patients; p = 0.676) were similar between the groups (63 patients matched paired). Intraoperative severe bleeding (EBL ≥ 492 mL) occurred in 44 patients. Multivariate analysis using the full cohort revealed that antithrombotic drug use was not an independent risk factor for severe bleeding and postoperative bleeding complications.
CONCLUSIONS CONCLUSIONS
This study demonstrated antithrombotic drugs do not adversely affect the perioperative outcomes of emergency gastrointestinal surgery.

Identifiants

pubmed: 34418977
doi: 10.1186/s12876-021-01897-0
pii: 10.1186/s12876-021-01897-0
pmc: PMC8380394
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

323

Informations de copyright

© 2021. The Author(s).

Références

Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
J Urol. 2008 Dec;180(6):2370-4; discussion 2734
pubmed: 18930273
World J Surg Oncol. 2019 Jun 1;17(1):92
pubmed: 31153382
Asian J Endosc Surg. 2020 Jan;13(1):33-38
pubmed: 30784217
Lancet. 2017 Jul 29;390(10093):490-499
pubmed: 28622955
Stat Appl Genet Mol Biol. 2006;5:Article19
pubmed: 17049030
Ann Thorac Surg. 2011 Mar;91(3):944-82
pubmed: 21353044
Anesthesiology. 2015 Feb;122(2):241-75
pubmed: 25545654
J Gastroenterol Hepatol. 2018 Feb;33(2):453-460
pubmed: 28696019
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
N Engl J Med. 2013 May 30;368(22):2113-24
pubmed: 23718166
JAMA Surg. 2017 Aug 1;152(8):768-774
pubmed: 28492821
Epilepsy Behav. 2017 May;70(Pt B):355-363
pubmed: 28237318
Surg Endosc. 2016 May;30(5):1762-70
pubmed: 26194260
Asian J Endosc Surg. 2020 Jul;13(3):359-365
pubmed: 31430063
Pharm Stat. 2011 Mar-Apr;10(2):150-61
pubmed: 20925139
Eur Heart J. 2018 Aug 14;39(31):2847-2850
pubmed: 30137444
Am J Surg. 2015 Apr;209(4):689-94
pubmed: 25064416
Nat Rev Drug Discov. 2011 Jan;10(1):61-75
pubmed: 21164526
J Trauma Acute Care Surg. 2015 Feb;78(2):306-11
pubmed: 25757115
Circulation. 2016 Jan 26;133(4):e38-360
pubmed: 26673558
Br J Anaesth. 2010 Mar;104(3):305-12
pubmed: 20150346
Med Sci Monit. 2007 May;13(5):CR224-30
pubmed: 17476194
Cardiovasc Interv Ther. 2013 Jan;28(1):16-21
pubmed: 22875747
Ann Surg. 2017 Feb;265(2):370-378
pubmed: 27049768
World J Emerg Surg. 2019 Dec 30;14:63
pubmed: 31892938
J Am Coll Surg. 2011 Jan;212(1):20-28.e1
pubmed: 21184955
Minim Invasive Ther Allied Technol. 2020 Aug;29(4):202-209
pubmed: 31116623
Updates Surg. 2015 Sep;67(3):301-4
pubmed: 25813428
World J Surg. 2015 Jan;39(1):139-49
pubmed: 25201469
Isr Med Assoc J. 2011 Jun;13(6):342-4
pubmed: 21809730
Br J Anaesth. 2011 Dec;107(6):899-910
pubmed: 21873632
Surg Endosc. 2018 Aug;32(8):3509-3516
pubmed: 29340825
Endoscopy. 2016 Apr;48(4):385-402
pubmed: 26890676
Int Surg. 2015 Feb;100(2):225-32
pubmed: 25692422
J Am Coll Surg. 2013 Dec;217(6):1044-53
pubmed: 24051069
World J Surg. 2012 Sep;36(9):2156-60
pubmed: 22547018
J Gastrointest Surg. 2007 Jul;11(7):903-10
pubmed: 17468915

Auteurs

Shinya Abe (S)

Department of Digestive Surgery, Kawakita General Hospital, 1-7-3 Kitaasagaya, Suginami-ku, Tokyo, 166-0001, Japan. sa61451689@gmail.com.

Katsunori Ami (K)

Department of Digestive Surgery, Kawakita General Hospital, 1-7-3 Kitaasagaya, Suginami-ku, Tokyo, 166-0001, Japan.

Akira Katsuno (A)

Department of Digestive Surgery, Kawakita General Hospital, 1-7-3 Kitaasagaya, Suginami-ku, Tokyo, 166-0001, Japan.

Noriyasu Tamura (N)

Department of Digestive Surgery, Kawakita General Hospital, 1-7-3 Kitaasagaya, Suginami-ku, Tokyo, 166-0001, Japan.

Toshiko Harada (T)

Department of Digestive Surgery, Kawakita General Hospital, 1-7-3 Kitaasagaya, Suginami-ku, Tokyo, 166-0001, Japan.

Shunsuke Hamasaki (S)

Department of Digestive Surgery, Kawakita General Hospital, 1-7-3 Kitaasagaya, Suginami-ku, Tokyo, 166-0001, Japan.

Yusuke Kitagawa (Y)

Department of Digestive Surgery, Kawakita General Hospital, 1-7-3 Kitaasagaya, Suginami-ku, Tokyo, 166-0001, Japan.

Taku Machida (T)

Department of Digestive Surgery, Kawakita General Hospital, 1-7-3 Kitaasagaya, Suginami-ku, Tokyo, 166-0001, Japan.

Naoyuki Umetani (N)

Department of Digestive Surgery, Kawakita General Hospital, 1-7-3 Kitaasagaya, Suginami-ku, Tokyo, 166-0001, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH